Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 3
2011 4
2012 4
2013 2
2014 19
2015 11
2016 8
2017 8
2018 6
2019 8
2020 4
2021 6
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Galectins-A Potential Target for Cardiovascular Therapy.
Ashraf GM, Perveen A, Zaidi SK, Ahmad A, Shakil S, Firoz CK, Jabir NR, Hassan I, Khan TA, Yarla NS, Tabrez S. Ashraf GM, et al. Among authors: shakil s. Curr Vasc Pharmacol. 2017;15(4):296-312. doi: 10.2174/1570161115666170201113046. Curr Vasc Pharmacol. 2017. PMID: 28155611 Review.
Linkage of Stress with Neuromuscular Disorders.
Ashraf GM, Ali A, Tabrez S, Zaidi SK, Shakil S, Alam MZ, Rehan M, Aliev G. Ashraf GM, et al. Among authors: shakil s. CNS Neurol Disord Drug Targets. 2016;15(3):321-8. doi: 10.2174/1871527315666160202124900. CNS Neurol Disord Drug Targets. 2016. PMID: 26831261 Review.
Current acetylcholinesterase-inhibitors: a neuroinformatics perspective.
Shaikh S, Verma A, Siddiqui S, Ahmad SS, Rizvi SM, Shakil S, Biswas D, Singh D, Siddiqui MH, Shakil S, Tabrez S, Kamal MA. Shaikh S, et al. Among authors: shakil s. CNS Neurol Disord Drug Targets. 2014 Apr;13(3):391-401. doi: 10.2174/18715273113126660166. CNS Neurol Disord Drug Targets. 2014. PMID: 24059296 Review.
Association of autoimmunity and cancer: An emphasis on proteolytic enzymes.
Tabrez S, Jabir NR, Khan MI, Khan MS, Shakil S, Siddiqui AN, Zaidi SK, Ahmed BA, Kamal MA. Tabrez S, et al. Among authors: shakil s. Semin Cancer Biol. 2020 Aug;64:19-28. doi: 10.1016/j.semcancer.2019.05.006. Epub 2019 May 14. Semin Cancer Biol. 2020. PMID: 31100322 Review.
Nanotechnology-based approaches in anticancer research.
Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Jabir NR, et al. Among authors: shakil s. Int J Nanomedicine. 2012;7:4391-408. doi: 10.2147/IJN.S33838. Epub 2012 Aug 9. Int J Nanomedicine. 2012. PMID: 22927757 Free PMC article. Review.
Inflammation targeted nanomedicines: Patents and applications in cancer therapy.
Praveen TK, Gangadharappa HV, Abu Lila AS, Moin A, Mehmood K, Krishna KL, Hussain T, Alafnan A, Shakil S, Rizvi SMD. Praveen TK, et al. Among authors: shakil s. Semin Cancer Biol. 2022 Nov;86(Pt 2):645-663. doi: 10.1016/j.semcancer.2022.04.004. Epub 2022 Apr 9. Semin Cancer Biol. 2022. PMID: 35405339 Review.
Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
Tabrez S, Priyadarshini M, Urooj M, Shakil S, Ashraf GM, Khan MS, Kamal MA, Alam Q, Jabir NR, Abuzenadah AM, Chaudhary AG, Damanhouri GA. Tabrez S, et al. Among authors: shakil s. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31(1):67-98. doi: 10.1080/10590501.2013.763577. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013. PMID: 23534395 Review.
81 results